Skip to content
TrialScanner

NCT01806610

Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease

Registry record

Lead sponsor
Ultragenyx Pharmaceutical Inc
Conditions
Chronic-kidney Disease Stage 5D on Stable Hemodialysis
Primary completion
Apr 2014Sponsor estimate
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Sponsor estimate: the sponsor registered this date in advance and can move it. A primary completion date is when the last participant is measured, not when results are announced.

Open NCT01806610 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01806610: Study of Safety and Tolerabil... | TrialScanner